Cyanotech (NASDAQ:CYAN) specializes in the production and sale of microalgae-based health and nutritional products, focusing on Spirulina and Astaxanthin which are used in dietary supplements as well as food and beverage applications. These microalgae are cultivated in its Kona, Hawaii facility, capitalizing on the unique climatic conditions to ensure high-quality production. Cyanotech's primary objective is to improve global health and nutrition by harnessing the potential of microalgae, aiming to expand its reach and product offerings through continuous research and development, sustainable practices, and innovative technology. The company is committed to environmental stewardship and aims to deliver value not only to its customers but also to its shareholders by maintaining high standards in its operational efficiency and product quality.